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A tri-compartment centrifugal electrospinning system (TCCES) was designed and used to fabricate multiple fiber membranes (from individual polyvinyl pyrrolidone (PVP), thermoplastic polyurethane (TPU) and poly-methyl methacrylate (PMMA) fibers). Controlled engineering of membrane composition presents opportunities to control mechanical and water contact angle characteristics. Furthermore, control on drug release rate is achieved based on active hosting fiber type contributing towards the overall membrane. The current system enables a high degree of alignment, production rate and variations to composition, indicating clear potential in biomedical fields requiring the use of encapsulated or embedded drug in membrane materials. 





Applications involving nanotechnology enabling platforms or products have diversified over the last decade, exhibiting potential in various health related remits such as pharmaceutical sciences, biomedical engineering [, ] and other medical fields [, ]. Within this area, miniaturized fibrous structures have attracted significant attention due to their unique properties [, ].
A considerable number of recent efforts have focused on nanofiber product engineering using the electrospinning (ES) technique, mainly due to its simplistic and versatile nature []. The process is ideal when small a quantity of material is required. The process, however, has several limitations for large-scale production [], which becomes more challenging when fiber alignment is a requirement. Aligned fibers have shown improved physical  ADDIN EN.CITE [] and biological properties [, ] in particular for  energy [, ], biomedicine [, ] and environmental applications []. Thus for the ES process, methods to improve fiber orientation have been investigated. These include rotating collection drum or disc [], frame collector [], parallel pair collection electrodes [] and centrifugal electrospinning [].
The successful construction of synthetic bionic tissue (such as cardiovascular [] HYPERLINK \l "_ENREF_5" \o "Repanas, 2015 #3" , tendon [], cartilage [], ligament [] and bone [, ]) has enormous medical and commercial impact, enabling several healthcare challenges to be addressed. For such tissue, fibers are composites in nature and aligned in structure [, ]. To date reliable and reproducible fabrication of aligned multi-fiber matrices on an industrial scale has been limited, but remains an area of crucial interest.
A recent engineering approach known as centrifugal electrospinning (CES) utilizes both centrifugal and electric field forces to stretch and elongate a polymer-liquid jet to yield polymeric fibers. Resulting fibers are highly aligned, although the mainstay of focus has been on congruence of a single type of polymeric material []. Whilst this is useful for several applications for bionic tissue [] the fibrous matrix comprises multiple materials.
Polyvinyl pyrrolidone (PVP) [], thermoplastic polyurethane (TPU) [], polymethyl methacrylate (PMMA) [] polymers have been widely used as excipients and materials for healthcare and biomedical applications. These polymers exhibit good biostability, low toxicity and appreciable biocompatibility. However, differences in their physical and mechanical properties suggest composites of such polymers will enable modulation of specific properties suitable for several bio applications.  





Polyvinyl pyrrolidone (PVP, mean Mw=1.3 x 106 g/mol), Polymethy methacrylate (PMMA, mean Mw=3.5 x 104 g/mol) and Rhodamine B (RB, mean Mw= 479.01 g/mol) were purchased from Sigma-Aldrich Ltd., St Louis, USA. Thermoplastic polyurethane (TPU) was purchased from Solvay China Ltd., Shanghai, China. Acriflavine (Ac, mean Mw = 259.73 g/mol) was purchased from Macklin, Shanghai, China. N,N-Dimethylformamide, Ethanol were purchased from Sinopharm Chemical Reagent Co., Ltd, Beijing, China. Tetracycline hydrochloride (TE-HCl) was purchased from Amresco, USA. Phosphate buffer saline (PBS) was supplied by Sinopharm Chemical Reagent Co., Ltd, Shanghai, China. All materials were of the analytical grade and were used as received without further purification. 

2.2 Preparation of spinning solution
20 wt% PVP solutions were prepared by dissolving 3.95 g polymer in 20 mL ethanol with continuous mechanical stirring (VELP ARE heating magnetic stirrer, Italy) at 25 ℃ for 3 h to ensure complete dissolution. 28.5 wt% TPU solutions were prepared by dissolving 7.47 g polymer in 20 mL N,N-dimethylformamide with continuous mechanical stirring at 50 ℃ for 24 h to ensure complete dissolution. The 15 wt% PMMA solution was prepared by 24 hour magnetic stirring at 20 ℃ in 20 mL N,N-dimethylformamide.

2.3 Characterization
2.3.1 An optical microscope (OM) (Pheonix BMC503-ICCF, China) was used to characterize the morphology and arrangement of centrifugal electrospinning fibers. Images were taken with a Scanning electron microscope (Hitachi, Japan). Prior to SEM analysis, samples were sputter-coated with Pt for 90 s using a current intensity of 25 mA (Sputter coater 108 auto, Cressington Scientific Instruments Ltd., UK). All samples were observed at an accelerating voltage of 20 kV and 500× magnification. 
2.3.2 Fluorescent micrographs were performed using an inverted microscope equipped with camera (DSQi2, Nikon, Tokyo, Japan). All samples were analyzed at 10× magnification. Polymer solutions were labeled through addition of 1 w/w% of selected fluorescent probe acriflavine (green, excitation in 440 nm) or rhodamine-B (red, excitation in 540 nm).
2.3.3 FTIR machine (IR Affinity 1, Shimadzu, Japan) was used to determined sample composition. Prior to test, samples were prepared using the KBr pellet pressing method, which need 2 mg of fibers dispersing in 200 mg of KBr medium by grinding and then compressed into transparent pellets (pressure = 20 MPa). The spectrum at a resolution of 4 cm−1 (4000 cm−1 – 400 cm−1) was used to test the pellets.
2.3.4 Optical contact angle meter (SL200KB, KINO Industry Co. Ltd., USA) was used to investigate hydrophobicity/hydrophilicity of aligned fibers with different materials (PMMA, PVP, TPU, PMMA-PVP, PMMA-TPU, PVP-TPU, PMMA-PVP-TPU). In order to get the similar thickness of the membranes, the collecting time of fibrous samples were all fixed at 1 min and subsequently samples were layered onto an object slide. A 3-axis horizontal tilt stage was used to perform measurements and the pictures and data of the water contact angle were obtained in the sessile drop mode at 25 °C. A water droplet (∼ 10 μL) was pipetted on to each membrane sample. The mean WCAs value of each sample were recorded 2 s after droplet release, when the droplet status acclimatized. The mean of three measurement readings was obtained.
2.4 Controlled release behavior. 
TE-HCl, LB, Ac were added into PMMA solution, TPU solution and PVP solution, respectively. The ratio of macromolecule and drug was fixed at 100:1. Antibiotic release of aligned fibers with different materials was determined by UV spectrophotometry (UV-2600 spectrophotometer, Shimadzu, Japan). A linear calibration curve of standard solutions ranging from 5-100 µg/mL was measured prior to the drug release studies. In the drug release tests, 20 mg of formulated drug loaded fiber was completely dissolved in 100 mL PBS. Thereafter the TE-HCl, LB and Ac concentration in PBS was determined using UV spectrophotometry at a wavelength of 356 nm, 554 nm and 451 nm, respectively. Samples were immersed in a sealed bottle containing 100 mL of PBS at temperature of 37 ℃ and were agitated (200 rpm) using a HZ-8801K thermostatic oscillator (Taicang Science and Education Factory, China).
Eqn. (1) was used to determine the cumulative release of TE-HCl ().
                                  Eqn. (1)
Where m is TE-HCl concentration in the solution at specified time points and M is the maximum concentration of TE-HCl in the solution. 

2.5 Differential scanning calorimetry (DSC). Differential scanning calorimetry (TA Q200, TA instruments, USA) was performed in the temperature range from 20 ℃ to 180 ℃. All samples were equilibrated at 20 ℃ and heated to 180 ℃ at a scanning rate of 10 ℃/min and after maintaining isothermal conditions at 180 ℃ for 1 min, samples were cooled to 20 ℃ at 10 ℃/min to finish the cycle. Approximately 8 mg was weighed from each sample into an open aluminum pan. All test runs were performed under nitrogen purging at 50 mL/min. All DSC measurements obtained through first heat scan.

2.6 Tensile tests.  A universal materials tester (Zwick/Roell Z020, Zwick, Germany) was used to test stress-strain performances of samples. The collecting time of all aligned fiber structures (PMMA, PVP, TPU, PMMA-PVP, PMMA-TPU, PVP-TPU, PMMA-PVP-TPU) was fixed at 1 min to get similar thickness, and samples possessing dimensions of 60 × 15 mm were assessed for mechanical properties. The selected gauge length was 10 mm, and samples were extended along the fiber axis with a 500 N load cell at a crosshead speed of 10 mm/min at the ambient temperature (20 °C). For each sample set, measurements were taken in triplicate. 

2.7 Image processing. ImageJ software (National Institute of Health, USA) analyzed the micrographs and provided the method of statistical distribution to quantify fiber diameters. In this method, each experiment involved a random sample of 100 fibers. Origin software (OriginLab, USA) exported all data for analysis while plotting graphs. Meanwhile, error bars were plotted to represent the mean and standard deviation. 

3.	Results and discussion
3.1	Centrifugal electrospinning system 
The centrifugal rotation spinneret is shown in Fig. 1(a) and hosts three individual polymer solution compartments. The complete TCCES system is shown in Fig. 1(b) and comprises a high voltage power supply (maximum ∼ 30 kV), a collector (12 stainless steel tubes, diameter = 70 mm) and the hosting spinneret. During CES processes, the high voltage power supply and rotating motor enable two impacting fiber forming forces: centrifugal and electric field. Fig. 1(c) shows a composite membrane fabricated using three polymeric solutions: PS (embedded with acriflavine probe, green), PVP (embedded with rhodamine-B probe, red) and PMMA (embedded with tetracycline hydrochloride, grey).

Fig.1. Centrifugal electrospinning system showing (a) schematic diagram of solution hosting spinneret with three compartments. (b) Complete TPCES system. (c) Schematic diagram and actual corresponding fluorescence micrograph of multi-fiber membrane. 

3.2	Fabrication of aligned fibers composite membranes 
Highly aligned fibers were generated using TCCES deploying an applied voltage of 18 kV and a spinneret rotation speed of 200 rpm. In addition, the collecting distance and inner diameter of CES needle were fixed at 70 and 0.3 mm, respectively. For exploratory experiments single-material aligned fibers were fabricated. In this instance individual polymer solutions (e.g. 15 wt.% PMMA solution, 20 wt.% PVP solution or 28.5 wt. % TPU solution) were spun from a single compartment. Figs. 2(a)(b)(c) show fabricated PMMA, PVP, TPU fibers, respectively. All fibers show high alignment, and corresponding mean diameters were 9.5±2.0, 2.2±0.6, 2.9±0.9 μm, respectively. PMMA fibers were most coarse, and although TPU and PVP fibers exhibit reduced mean diameters, there was no significant difference between the two. Fiber diameter ranged from 0.8 – 4.0 μm for PVP and 1.8 – 6.0 μm for TPU. 

Figs. 2(d)(e)(f) show aligned fiber membranes formed using two materials in independent compartments (1:1 ratio). PMMA-PVP and PMMA-TPU composite membranes display two diameter distribution ranges, which correlate with exploratory studies of single material CES. Membranes comprising PMMA, PVP and TPU aligned fibers were generated using a 1:1:1 compartment ratio. As evidenced previously, diameter distribution of the tri-material composite membrane comprises a large diameter distribution (PMMA) alongside a broad range for reduced diameters (TPU and PVP).


Fig. 2. Optical micrographs of aligned fibers obtained using different materials and corresponding fiber diameter distribution. (a) PMMA, (b) PVP, (c) TPU, (d) PMMA-PVP, (e) PMMA-TPU, (f) PVP-TPU, (g) PMMA-PVP-TPU. (Collection time: 1 min)

  Rhodamine B and Acridine (both at ~ 1 w/v. %) were incorporated into TPU and PVP solutions, respectively, prior to CES. Fig.3 shows corresponding individual and over-layered fluorescent micrographs. PMMA fibers observed in visible light appear gray (Fig. 3(a)). PVP and TPU fibers appear green at 440 nm (Fig. 3(b)) and red at 540 nm (Fig. 3(c)), respectively. Fluorescence images of two material composite membrane is shown in Figs. 3(d)(e)(f). The corresponding colors indicate the presence and location of each fiber type. Grey (PMMA), green (PVP) and red (TPU) fibers are shown in an over-layered fluorescent micrograph (Fig. 3(g)), confirming simultaneous engineering of polymer fiber composite membranes. In addition, through imaging capability, active material retention and carrier potential is shown. 

Corresponding scanning electron micrographs show fibers to possess smooth surface morphology which are well defined without fiber merging phenomenon. Static water contact angles on single material membranes (PMMA, PVP and TPU) were 116.5 ± 2.7 °, 49.7 ± 0.5 ° and 102.0 ± 0.5 °, respectively. PVP membranes are hydrophilic in nature, while PMMA and TPU are hydrophobic. For two-material membranes the water contact angles of PMMA-PVP, PMMA-TPU and PVP-TPU composites were 86.3 ± 3.8 °, 112.5 ± 1.4 ° and 66.9 ± 0.7 °, respectively. Water contact angle values obtained for composites show a compromise between hydrophilic/hydrophobic properties of materials. Similarly, membranes consisting of PMMA, PVP and TPU exhibit water contact angle values of 87.9 ± 0.4 °. Hence, fabrication of composite fibers enable modulation of surface wettability, which is crucial for bio-interface applications.
Fig. 3(h) shows FTIR spectra focusing in the 4000-400 cm-1 region. For PMMA spectrum, the band at 1730 cm-1 is attributed to C=O vibration [], and the peak at 751 cm-1 corresponds to C-H out of plane bending []. Characteristic absorption peaks at 1658 cm-1 and 1288 cm-1 are observed for PVP, which are assigned to C=O and C-N vibrations, respectively []. The spectrum for TPU shows two characteristic IR regions, absorption peaks at 1530 cm-1 correspond to deformation vibration of (-NH-) bonds in urethane (-NHCOO-) group from amide II and the peak at 1692 cm-1 represents (-C=O) stretching in urethane group from amide I []. Compared to single material membranes, spectrum for those comprising both PVP and TPU exhibit characteristic peaks observed for pristine materials. Similarly, characteristic absorption peaks at 1730 and 1288 cm-1 are observed for PMMA-PVP membranes, and peaks at 1730 and 1530 cm-1 are observed for the PMMA-TPU composite. The spectrum for PMMA-PVP-TPU exhibits all characteristic peaks, with no other absorption bands being detected in composite fibers, confirming no new chemical bond formation or significant intermolecular interactions arising within blended membranes.


Fig. 3. Fluorescent and electron micrographs of aligned fibers using different materials and corresponding water contact angles. (a) PMMA, (b) PVP, (c) TPU, (d) PMMA-PVP, (e) PMMA-TPU, (f) PVP-TPU, (g) PMMA-PVP-TPU. Corresponding FTIR spectra are shown in (h).

Fig. 4(a) shows differential scanning calorimetry plots for aligned PMMA, TPU, PVP and PMMA-PVP-TPU fiber systems. Melting and crystallization peaks are not observed for TPU, suggesting TPU exists in an amorphous state []. Amorphous PVP fibers show a glass transition temperature (Tg) at 47 °C [], and for PMMA is observed at 102 °C []. Fibers contributing towards composite membrane do not impact the overall thermodynamic properties, as three is no new glass transition temperature. In addition, due to the hygroscopic nature of materials [] and moisture accumulation post ES process [], both PVP and PMMA fibers show relevant endothermic peaks between 100 to 130 °C.
  Fig. 4(b) shows stress-strain curves for aligned PMMA, TPU, PVP and PMMA-PVP-TPU fiber membranes. Using single-material membranes, tensile strain for PMMA and PVP systems were 1.1 ± 0.2% and 14.4 ± 2.4%, respectively, and corresponding tensile strength were 14.4 and 25.5 MPa, respectively. In contrast, TPU membranes withstand stretching up to 256.1 ± 3.5%, exhibiting a maximum tensile strength of ~13.6 MPa. PVP and PMMA have poor fiber drawability while TPU fibers are more ductile. For the composite PMMA-PVP-TPU system the maximum tensile strain was 208.5 ± 4.0% and the maximum tensile strength was ~6.8 MPa. The high extension property of TPU leads to this marked difference between composite and PMMA/PVP membranes. However, the composite membrane still shows corresponding tensile stress peaks for PMMA and PVP.


Fig. 4. Physical and mechanical analysis of aligned fiber membranes (a) DSC analysis, (b) Stress-strain analysis.

Single drug (TE-HCl) release behavior from several aligned fibrous membranes was investigated. As shown in Fig. 5(a), pristine PVP membranes possessed the fastest drug release rate amongst all single-material systems (PMMA, PVP, TPU) and cumulative release reached 98.7 ± 1.1 % at 1 h test period. Pure TPU membranes show moderate release behavior, with cumulative release reaching 65.8 ± 0.6% at 72 h. Finally, PMMA systems show the greatest sustained release rate, with only 46.3 ± 0.9 % of TE-HCL released at 144 h. 
Differences in drug release behavior from the three pristine materials was used to modulate release kinetics. TPU-PVP composite membranes show rapid drug release in the first hour exhibiting cumulative release of 47.9 ± 0.8%, which increases to 76.9 ± 0.3% at 72 h. The combination of these two materials enables "rapid and intermediate” release attributes of the antimicrobial drug. Similarly, PMMA-PVP membranes also demonstrate bi-phasic drug release behavior, although the sustained release phase was over a 144 h period (76.5 ± 0.8%). Cumulative release from TPU-PMMA membranes was 50.2 ± 0.6% at 72 h and 53.1 ± 0.2% at 144 h. When using the tri-material PMMA-PVP-TPU membrane a three tiered release pattern of TE-HCl is observed. Here, cumulative drug release reached 41.4 ± 0.5% at 1 h, 65.2 ± 0.5% at 72 h and 68.3 ± 1.4% at 144 h. Controlled drug release from such membranes is ideally suited for potential medicated fibrous device development (e.g. wound dressing), rapid and massive release of antibacterial drugs destroy wound bacteria, and subsequent continued slow drug release inhibit bacterial growth in mid-late stage [].




Fig. 5. Drug and model active release analysis. (a) Single drug (TE-HCl) release from one fiber type membranes. (b) Multi- drug (TE-HCl, TE, RB) release from aligned fibers using different hosting materials. (c) Two-material composite aligned fiber membranes releasing two actives (PMMA-PVP, PMMA-TPU, PVP-TPU). (d) Three-material composite aligned fiber membranes releasing three actives (PMMA-PVP-TPU). 

4.	Conclusion
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